Soluble E-selectin in cancer patients as a marker of the...

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

Barbara D. Wamil, Gary B. Thurman, Hakan W. Sundell, Russel F. DeVore, Gail Wakefield, David H. Johnson, Yue-Fen Wang, Carl G. Hellerqvist
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
123
Year:
1997
Language:
english
Pages:
7
DOI:
10.1007/bf01214670
File:
PDF, 703 KB
english, 1997
Conversion to is in progress
Conversion to is failed